financetom
Business
financetom
/
Business
/
BTCS Insider Bought Shares Worth $261,425, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BTCS Insider Bought Shares Worth $261,425, According to a Recent SEC Filing
Nov 19, 2025 3:04 PM

05:33 PM EST, 11/19/2025 (MT Newswires) -- Charles W Allen, Director, CEO, on November 18, 2025, executed a purchase for 90,500 shares in BTCS (BTCS) for $261,425. Following the Form 4 filing with the SEC, Allen has control over a total of 9,336,512 common shares of the company, with 4,666,506 shares held directly and 4,670,006 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1436229/000149315225024337/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Intel CEO's Past China Investments Raise Security Concerns
Market Chatter: Intel CEO's Past China Investments Raise Security Concerns
Apr 10, 2025
07:16 AM EDT, 04/10/2025 (MT Newswires) -- Intel ( INTC ) chief executive officer Lip-Bu Tan has backed hundreds of Chinese tech ventures, including at least eight with links to China's military, Reuters reported Thursday, citing a review of Chinese and US regulatory documents. Tan owns or controls more than 600 entities in China through investment vehicles such as Walden...
Ideaya Biosciences Begins Phase 1/2 Expansion in Urothelial Cancer Treatment Trial in Combination With Gilead's Trodelvy
Ideaya Biosciences Begins Phase 1/2 Expansion in Urothelial Cancer Treatment Trial in Combination With Gilead's Trodelvy
Apr 10, 2025
07:18 AM EDT, 04/10/2025 (MT Newswires) -- Ideaya Biosciences ( IDYA ) said Thursday it launched a phase 1/2 expansion in a clinical trial of its experimental IDE397 treatment in combination with Gilead Sciences' ( GILD ) Trodelvy in methylthioadenosine phosphorylase, or MTAP-deletion urothelial cancer, based on preliminary safety and clinical efficacy data. The prevalence of MTAP-deletion is estimated at...
BRIEF-Laser Photonics Sees Benefit From Proposed U.S. Trade Policies
BRIEF-Laser Photonics Sees Benefit From Proposed U.S. Trade Policies
Apr 10, 2025
April 10 (Reuters) - Laser Photonics Corp ( LASE ): * LASER PHOTONICS STRENGTHENS MARKET POSITION THROUGH STRATEGIC VERTICAL INTEGRATION AND ACQUISITION OF RECESSION-RESISTANT ASSETS * LASER PHOTONICS CORP ( LASE ) - SEES BENEFIT FROM PROPOSED U.S. TRADE POLICIES Source text: Further company coverage: ;)) ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved